Purification and characterization of Mycobacterium tuberculosis KatG, KatG(S315T), and Mycobacterium bovis KatG(R463L)

Protein Expression and Purification

Volumn 36, Issue 2, 2004, Pages 232-243

  Wengenack, Nancy L ^a,c   Lane, Brian D ^a   Hill, Preston J ^b   Uhl, James R ^c   Lukat Rodgers, Gudrun S ^d   Hall, Leslie ^c   Roberts, Glenn D ^c   Cockerill III, Franklin R ^c   Brennan, Patrick J ^b   Rodgers, Kenton R ^d   Belisle, John T ^b   Rusnak, Frank ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b Department of Environmental and Radiological Health Sciences   (United States)

^c MAYO CLINIC   (United States)

^d NORTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

KatG; Mycobacterium bovis; Mycobacterium tuberculosis

Indexed keywords

BACTERIAL PROTEIN; CATALASE; ISONIAZID; KATG PROTEIN, MYCOBACTERIUM TUBERCULOSIS; RECOMBINANT PROTEIN;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; CHEMISTRY; DIET THERAPY; ENZYME SPECIFICITY; ENZYMOLOGY; GENETICS; ISOLATION AND PURIFICATION; KINETICS; METABOLISM; MICROBIOLOGY; MYCOBACTERIUM BOVIS; OXIDATION REDUCTION REACTION; PATHOLOGY; POINT MUTATION; PROTEIN BINDING; SPECTROSCOPY; TUBERCULOSIS;

AMINO ACID SUBSTITUTION; BACTERIAL PROTEINS; CATALASE; DRUG RESISTANCE, BACTERIAL; ISONIAZID; KINETICS; MYCOBACTERIUM BOVIS; OXIDATION-REDUCTION; POINT MUTATION; PROTEIN BINDING; RECOMBINANT PROTEINS; SPECTRUM ANALYSIS; SUBSTRATE SPECIFICITY; TUBERCULOSIS;

ESCHERICHIA COLI; MYCOBACTERIUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS;

EID: 3142531318     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2004.04.018     Document Type: Article

References (44)

1. The World Health Report, in: World Health Organization (2001)
2. Global Tuberculosis Programme. Anti-tuberculosis Drug Resistance in the World., in: World Health Organization (1998)
3. Vareldzis B.P., Grosset J., de Kantor I., Crofton J., Laszlo A., Felten M., Raviglione M.C., Kochi A. Drug-resistant tuberculosis: laboratory issues. Tuber. Lung Dis. 75:1994;1-7
4. Telenti A. Genetics of drug resistant tuberculosis. Thorax. 53:1998;793-797
5. Rattan A., Kalia A., Ahmad N. Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives. Emerg. Infect. Dis. 4:1998;195-209
6. Global Tuberculosis Programme. TB Fact Sheet, in: World Health Organization (2000)
7. The Global Impact of Drug-resistant Tuberculosis, in: Harvard Medical School and The Open Society Institute, Boston, MA (1999) pp. 1-258
8. Kling J. Russian jailhouse genomics. Enlisting a genome to fight MDR tuberculosis. Mod. Drug Discov. 2:1999;32-45
9. Sander P., Bottger E.C. Mycobacteria: genetics of resistance and implications for treatment. Chemotherapy. 45:1999;95-108
10. Zhang Y., Heym B., Allen B., Young D., Cole S. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature. 358:1992;591-593
11. Zhang Y., Garbe T., Young D. Transformation with katG restores isoniazid-sensitivity in Mycobacterium tuberculosis isolates resistant to a range of drug concentrations. Mol. Microbiol. 8:1993;521-524
12. Johnsson K., Schultz P.G. Mechanistic studies of the oxidation of isoniazid by the catalase peroxidase from Mycobacterium tuberculosis. J. Am. Chem. Soc. 116:1994;7425-7426
13. Marcinkeviciene J.A., Magliozzo R.S., Blanchard J.S. Purification and characterization of the Mycobacterium smegmatis catalase-peroxidase involved in isoniazid activation. J. Biol. Chem. 270:1995;22290-22295
14. Wengenack N.L., Uhl J.R., St.Amand A.L., Tomlinson A.J., Benson L.M., Naylor S., Kline B.C., Cockerill F.R., Rusnak F. Recombinant Mycobacterium tuberculosis KatG(S315T) is a competent catalase-peroxidase with reduced activity toward isoniazid. J. Infect. Dis. 176:1997;722-727
15. Wengenack N.L., Todorovic S., Yu L., Rusnak F. Evidence for differential binding of isoniazid by Mycobacterium tuberculosis KatG and the isoniazid-resistant mutant KatG(S315T). Biochemistry. 37:1998;15825-15834
16. Johnsson K., Froland W.A., Schultz P.G. Overexpression, purification, and characterization of the catalase-peroxidase KatG from Mycobacterium tuberculosis. J. Biol. Chem. 272:1997;2834-2840
17. Wengenack N.L., Hoard H.M., Rusnak F. Isoniazid oxidation by Mycobacterium tuberculosis KatG: A role for superoxide which correlates with isoniazid susceptibility. J. Am. Chem. Soc. 121:1999;9748-9749
18. Saint-Joanis B., Souchon H., Wilming M., Johnsson K., Alzari P.M., Cole S.T. Use of site-directed mutagenesis to probe the structure, function and isoniazid activation of the catalase/peroxidase, KatG, from Mycobacterium tuberculosis. Biochem. J. 338:1999;753-760
19. Magliozzo R.S., Marcinkeviciene J.A. Evidence for isoniazid oxidation by oxyferrous mycobacterial catalase-peroxidase. J. Am. Chem. Soc. 118:1996;11303-11304
20. Magliozzo R.S., Marcinkeviciene J.A. The role of Mn(II)-peroxidase activity of mycobacterial catalase-peroxidase in activation of the antibiotic isoniazid. J. Biol. Chem. 272:1997;8867-8870
21. Zabinski R.F., Blanchard J.S. The requirement for manganese and oxygen in the isoniazid-dependent inactivation of Mycobacterium tuberculosis enoyl reductase. J. Am. Chem. Soc. 119:1997;2331-2332
22. Gayathri Devi B., Ramakrishnan T., Gopinathan K.P. Studies on an enzyme reacting with isoniazid from Mycobacterium tuberculosis H37Rv. Proc. Indian Acad. Sci. Sect. B. 80:1974;240-252
23. Gayathri Devi B., Shaila M.S., Ramakrishnan T., Gopinathan K.P. The purification and properties of peroxidase in Mycobacterium tuberculosis H37Rv and its possible role in the mechanism of action of isonicotinic acid hydrazide. Biochem. J. 149:1975;187-197
24. Wengenack N.L., Jensen M.P., Rusnak F., Stern M.K. Mycobacterium tuberculosis KatG is a peroxynitritase. Biochem. Biophys. Res. Commun. 256:1999;485-487
25. Wang J.-Y., Burger R.M., Drlica K. Role of superoxide in catalase-peroxidase-mediated isoniazid action against mycobacteria. Antimicrob. Agents Chemother. 42:1998;709-711
26. Bulatovic V., Wengenack N.L., Uhl J.R., Hall L., Roberts G., Cockerill III F.R., Rusnak F. Oxidative stress increases susceptibility of Mycobacterium tuberculosis to isoniazid. Antimicrob. Agents Chemother. 46:2002;2765-2771
27. Musser J.M., Kapur V., Williams D.L., Kreiswirth B.N., van Soolingen D., van Embden J.D.A. Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance. J. Infect. Dis. 173:1996;196-202
28. Victor T.C., Pretorius G.S., Felix J.V., Jordaan A.M., van Helden P.D., Eisenach K.D. katG mutations in isoniazid-resistant strains of Mycobacterium tuberculosis are not infrequent. Antimicrob. Agents Chemother. 40:1996;1572
29. Ramaswamy S., Musser J.M. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber. Lung Dis. 79:1998;3-29
30. Barry III C.E., Slayden R.A., Mdluli K. Mechanisms of isoniazid resistance in Mycobacterium tuberculosis. Drug Resist. Updat. 1:1998;128-134
31. Heym B., Alzari P.M., Honore N., Cole S.T. Missense mutations in the catalase-peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosis. Mol. Microbiol. 15:1995;235-245
32. Rouse D.A., DeVito J.A., Li Z., Byer H., Morris S.L. Site-directed mutagenesis of the katG gene of Mycobacterium tuberculosis: effects on catalase-peroxidase activities and isoniazid resistance. Mol. Microbiol. 22:1996;583-592
33. Rouse D.A., Li Z., Bai G.H., Morris S.L. Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 39:1995;2472-2477
34. Uhl J.R., Sandhu G.S., Kline B.C., Cockerill III F.R. PCR-RFLP detection of point mutations in the catalase-peroxidase gene (katG) of Mycobacterium tuberculosis associated with isoniazid resistance. Persing D. PCR Protocols for Emerging Infectious Diseases. 1996;144-149 ASM Press, Washington, DC
35. Dhandayuthapani S., Zhang Y., Mudd M.H., Deretic V. Oxidative stress response and its role in sensitivity to isoniazid in mycobacteria: characterization and inducibility of ahpC by peroxides in Mycobacterium smegmatis and lack of expression in M. aurum and M. tuberculosis. J. Bacteriol. 178:1996;3641-3649
36. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254
37. Lukat-Rodgers G.S., Wengenack N.L., Rusnak F., Rodgers K.R. Spectroscopic comparison of the heme active sites in WT KatG and its S315T mutant. Biochemistry. 39:2000;9984-9993
38. Shoeb H.A., Bowman B.U., Ottolenghi A.C., Merola A.J. Evidence for the generation of active oxygen by isoniazid treatment of extracts of Mycobacterium tuberculosis H37Ra. Antimicrobial Agents and Chemotherapy. 27:1985;404-407
39. van Zyl J.M., van der Walt B.J. Apparent hydroxyl radical generation without transition metal catalysis and tyrosine nitration during oxidation of the anti-tubercular drug, isonicotinic acid hydrazide. Biochem. Pharmacol. 48:1994;2033-2042
40. Maehly A.C. Plant peroxidase. Methods Enzymol. 2:1955;801-813
41. Chouchane S., Lippai I., Magliozzo R.S. Catalase-peroxidase (Mycobacterium tuberculosis KatG) catalysis and isoniazid activation. J. Am. Chem. Soc. 39:2000;9975-9983
42. Choi S., Spiro T.G., Langry K.C., Smith K.M., Budd D.L., LaMar G.N. Structural correlations and vinyl influences in resonance Raman spectra of protoheme complexes and proteins. J. Am. Chem. Soc. 104:1982;4345-4351
43. Spiro T.G., Li X.Y. Spiro T.G. Biological Applications of Raman Spectroscopy. 1988;1-37 John Wiley, New York
44. Nagy J.M., Cass A.E.G., Brown K.A. Purification and characterization of recombinant catalase-peroxidase, which confers isoniazid sensitivity in Mycobacterium tuberculosis. J. Biol. Chem. 272:1997;31265-31271